Director · SUPERNUS PHARMACEUTICALS, INC. · SUPERNUS PHARMACEUTICALS, INC. — Director Stock Option (Right to Buy)
Side
J
Value
—
Shares
8,252
Price
—
Executed
Nov 2, 2026
Disclosed
Nov 4, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 2 executedNov 4, 2026 disclosed
SUPN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
SUPERNUS PHARMACEUTICALS, INC. — Director Stock Option (Right to Buy)
Ticker
SUPN
Shares
8,252
Price per share
$0
Execution date (reported)
Nov 2, 2026
Owned after transaction
0 shares
Days from execution to publication
2
What this establishes
Barlow Carrolee filed this Form 4 reporting a other acquisition or disposition of SUPN on Nov 2, 2026. It became public on Nov 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Barlow Carroleecik:0001745316
Issuer
SUPERNUS PHARMACEUTICALS, INC.cik:0001356576
Revision history · 0
No field has changed since this record was first ingested.
